Clinical Laserthermia Systems AB (publ) (ST:CLS-B) — Stock Price

Skr1.90 SEK
▲ 3.49% today

Clinical Laserthermia Systems AB (publ) (ST:CLS-B) is currently trading at Skr1.90 SEK, up 3.49% today. Over the past 52 weeks, shares have ranged between Skr1.80 and Skr11.82. This page tracks Clinical Laserthermia Systems AB (publ)'s live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CLS-B market cap.

Clinical Laserthermia Systems AB (publ) (CLS-B) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Clinical Laserthermia Systems AB (publ)'s daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Clinical Laserthermia Systems AB (publ) Income Statement — Revenue, Profit & Earnings by Year

Clinical Laserthermia Systems AB (publ)'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr17.49 Million Skr18.78 Million Skr8.27 Million Skr6.27 Million Skr2.25 Million
Cost of Revenue Skr46.48 Million Skr8.36 Million Skr5.28 Million Skr9.06 Million Skr5.88 Million
Gross Profit Skr-29.00 Million Skr10.42 Million Skr3.00 Million Skr-2.79 Million Skr-3.63 Million
Research & Development Skr2.13 Million Skr2.13 Million Skr2.10 Million
SG&A Skr42.64 Million
Total Operating Expenses Skr46.30 Million Skr64.67 Million Skr68.93 Million Skr64.65 Million Skr56.98 Million
Operating Income Skr-29.00 Million Skr-54.25 Million Skr-65.93 Million Skr-67.44 Million Skr-60.68 Million
EBITDA Skr-26.41 Million Skr-44.76 Million Skr-68.41 Million Skr-57.84 Million Skr-57.05 Million
EBIT Skr-29.00 Million Skr-47.43 Million Skr-71.11 Million Skr-60.29 Million Skr-57.74 Million
Interest Expense Skr233.00K Skr433.00K Skr9.76 Million Skr10.97 Million Skr6.41 Million
Income Before Tax Skr-42.05 Million Skr-47.86 Million Skr-80.88 Million Skr-71.27 Million Skr-64.14 Million
Income Tax Expense Skr-1.08 Million Skr-576.00K Skr5.88 Million
Net Income Skr-41.61 Million Skr-47.62 Million Skr-79.79 Million Skr-70.66 Million Skr-63.62 Million

Clinical Laserthermia Systems AB (publ) Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Clinical Laserthermia Systems AB (publ)'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr76.49 Million Skr78.56 Million Skr57.73 Million Skr49.51 Million Skr66.74 Million
Total Current Assets Skr39.12 Million Skr38.41 Million Skr27.14 Million Skr24.26 Million Skr42.42 Million
Cash & Equivalents
Short-term Investments Skr139.49K Skr29.46 Million
Net Receivables Skr4.88 Million Skr7.61 Million Skr3.98 Million Skr8.40 Million Skr6.45 Million
Inventory Skr12.70 Million Skr8.15 Million Skr6.12 Million Skr1.50 Million Skr4.16 Million
Property, Plant & Equipment Skr1.80 Million Skr1.48 Million
Goodwill
Total Liabilities Skr10.00 Million Skr12.88 Million Skr14.20 Million Skr41.64 Million Skr45.55 Million
Total Current Liabilities Skr10.00 Million Skr12.87 Million Skr13.97 Million Skr41.64 Million Skr45.45 Million
Long-term Debt Skr223.00K Skr0.00 Skr100.00K
Net Debt Skr-21.55 Million Skr-22.28 Million Skr-14.88 Million Skr20.23 Million Skr-1.43 Million
Total Stockholder Equity Skr69.67 Million Skr68.72 Million Skr45.77 Million Skr9.22 Million Skr21.79 Million
Retained Earnings Skr-13.80 Million Skr-19.88 Million Skr16.99 Million Skr-410.70 Million Skr-327.52 Million

Clinical Laserthermia Systems AB (publ) Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Clinical Laserthermia Systems AB (publ) generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr-33.20 Million Skr-56.45 Million Skr-66.45 Million Skr-70.69 Million Skr-66.17 Million
Capital Expenditures Skr2.70 Million Skr2.46 Million Skr5.50 Million Skr562.00K Skr555.00K
Free Cash Flow Skr-35.91 Million Skr-58.92 Million Skr-71.95 Million Skr-71.25 Million Skr-66.73 Million
Investing Cash Flow Skr-2.80 Million Skr-7.47 Million Skr-5.50 Million Skr-886.00K Skr-408.00K
Financing Cash Flow Skr35.04 Million Skr71.10 Million Skr76.69 Million Skr61.84 Million Skr85.88 Million
Dividends Paid
Stock-Based Compensation
Depreciation Skr2.58 Million Skr2.67 Million Skr2.71 Million Skr2.45 Million Skr683.50K
Change in Cash Skr-960.00K Skr7.17 Million Skr4.74 Million Skr-20.58 Million Skr19.29 Million

Clinical Laserthermia Systems AB (publ) Earnings History — EPS Actual vs. Analyst Estimates

Track Clinical Laserthermia Systems AB (publ)'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 14, 2026 -0.24
Feb 21, 2026 -0.39
Nov 14, 2025 -0.32
Aug 15, 2025 -0.25
May 16, 2025 -0.71
Feb 21, 2025 -0.43
Oct 31, 2024 -0.98
Aug 23, 2024 -0.01